Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2019-08-06 2019-06-12
Drug Identification Number 00030600 00030600
Brand name SOLU-CORTEF 100 MG ACT-O-VIAL SOLU-CORTEF 100 MG ACT-O-VIAL
Common or Proper name SOLU-CORTEF SOLU-CORTEF
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HYDROCORTISONE HYDROCORTISONE
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 X 2mL AOV 10 X 2mL AOV
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-11 2019-06-11
Estimated end date 2019-09-20
Actual end date 2019-08-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments